Share on LinkedInShare on LinkedIn

ARTICLE · 01 JUNE 2020

COVID-19: Restrictions On Promoting Medicines

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

In accordance with general precautions established by the government due to the COVID-19 pandemic, the Turkish Medicines and Medical Devices Agency published new arrangements in March.

TurkeyCoronavirus (COVID-19)

In accordance with general precautions established by the government due to the COVID-19 pandemic, the Turkish Medicines and Medical Devices Agency published new arrangements in March 2020 on promotional activities concerning medicines to encourage social isolation.

On 19 March, the Agency published an announcement (Turkish language) indicating that product promotion representatives of the pharmaceutical companies must cease visiting health institutions and establishments, including pharmacies, until a further announcement is made by the Agency. Product promotion representatives must conduct those activities electronically (that is, by email or video conferencing).

On 31 March, the Agency published an announcement (Turkish language) permitting marketing authorisation holders to organise or sponsor web-based promotional meetings that are accessible by all participants using computers only. An application must be made to the Agency for those meetings in accordance

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from